Trends Hemorrhoids Treatment Market 2017-2025

Hemorrhoids is a gastrointestinal disorder mostly afflicting adults. Hemorrhoids are caused by the swelling of veins near the anal tissue. Usually this tissue acts like a cushion, but during the strain caused by obesity or pregnancy, these veins are pressurized and they swell leading to the formation of hemorrhoids inside or outside the anal region. Generally, hemorrhoids are known as piles. Hemorrhoids found inside the rectum are called internal hemorrhoids and those which grow in the anal area, outside the rectum are called external hemorrhoids. The symptoms of the disease are uncomfortable conditions like bleeding in the stools, itching and pain during bowel movements, and swelling and inflammation in the anal area. It is estimated that around 33% of population under the age of 50 and 50% of population above the age of 50 suffer from this condition. However, only one-third of the affected population seek medical help, out of which most prefer OTC treatment. Proper diagnosis is crucial if symptoms related to hemorrhoids are felt. Diagnosis can be performed by a doctor for complete rectal examination, a proctoscopic examination, and colonoscopy if required because certain other disorders like rectal cancer or colon cancer have similar symptoms like hemorrhoids

Request Sample Copy of the Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28529
The global prenatal care market is driven by various factors such as increasing incidence of preterm child births, growing awareness about prenatal care, and rising demand for various prenatal products, therapeutics, diagnostics, and monitoring equipment. Additionally, government initiatives for prenatal and neonatal care are likely to drive the market in the near future. Moreover, increase in distribution channels such as supermarkets, online stores, retail stores, and pharmacies are likely to fuel the growth of the pregnancy products market in the near future. Furthermore, rise in teen pregnancies in Southern United States is projected to propel the prenatal market in the region. Growing awareness about prenatal care has led to increase in expenditure on baby care products to provide the right care to babies. However, the global recession, increase in working women population, and single child family are the factors hampering market growth. Nevertheless, governments in some countries are taking action to offset these restraints by providing subsidies to families with more children.

The global prenatal care market has been segmented based on product type, distribution channel, and region. In terms of product type, the market has been segmented into skin toning lotions, body restructuring gels, stressed leg products, breast products, stretch mark minimizers, and dark spot treatment creams. The stretch marks minimizers segment is projected to account for the largest share of the market during the forecast period. Growth of the segment is attributed to increasing popularity and enhanced results shown by these products. Based on distribution channel, the prenatal care market has been segmented into hospital pharmacies, online pharmacies, supermarkets, and drug stores. Geographically, the prenatal care market has been segmented into five major regions: North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America is expected to dominate the global market during the forecast period owing to increase in female population and significant rise in the number of pregnancies in the past few years. Around 4 million births take place in the U.S. each year. This is the most developed market for prenatal products, with high average spending among parents-to-be for healthy child.

Major players in the market are Nine Naturals, LLC, Mama Mio US Inc., Clarions Group, Expanscience Laboratories, Inc., and Noodle & Boo.

The driving factors responsible for the growth of the hemorrhoids treatment market include a sedentary lifestyle, lack of physical exercise, obesity, alcoholism, poor fiber intake in diet etc. in most of the developed countries. Lack of awareness and preparedness for medical treatment due to a feeling of embarrassment hinders the growth of the market.

The hemorrhoids treatment market is segmented on the basis of type of treatment, route of administration, and as per distribution channel. On the basis of treatment type, it can be further segmented into different type of drugs (which include laxatives, NSAIDs, and herbals), diet, type of non-surgical procedures like rubber band litigation, sclerotherapy, cryotherapy etc. and surgical procedures. However, drug treatment and surgical treatment is needed only in severe cases. Initially, diet and lifestyle change is the best option to cure hemorrhoids. Diet should include more fibers, fruits, vegetables, nuts, legumes etc. Lifestyle modification can include adopting some physical exercise, taking proper rest, and getting sufficient sleep. Drug treatment includes laxatives, anorectics, topical steroids, anesthetics etc. Amongst non-operative treatments, rubber band litigation is the most commonly used procedure for the first, second, or third degree of hemorrhoids and in some cases for the fourth degree of hemorrhoids as well. On the basis of route of administration, it is segmented into oral or topical agents. Oral agents include orally administered drugs like lamotrigine. Topical treatments can include creams, ointments, gels etc. Out of these, creams cover the largest market share globally and are selected as the first choice of treatment in case of hemorrhoids. On the basis of distribution channel, the classification includes retail pharmacies, hospital pharmacies, online pharmacies and others. Amongst these, retail pharmacies have the dominant market share currently. However, online pharmacies are gaining importance slowly through technical advancement.

Geographically, the global hemorrhoids treatment market can be distributed into five regions. These include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America and Europe markets are expected to expand during the forecast period, owing to the rise in demand for advanced treatment, increase in health care expenditure, and increased diagnosis rate.

Pfizer, Ranbaxy, Himalaya, Astra Zeneca, Glenmark Pharmaceuticals, GlaxoSmithKline Plc. etc. are the major market players responsible for the growth of the most common gastro-intestinal disorders.s

Request TOC of the Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=28529

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.